16 July 2024Helge Lubenow becomes Chief Executive Officer, succeeding founder David Jones, who continues with the company as Chief Scientific Officer.
2 July 2024A €4.3M seed round led by CARMA FUND I, with High-Tech Gründerfonds, LBBW Venture Capital and Start-up BW, to accelerate brain tumour classification.
